Evidence map›Paper›PMID 30332737›Full record

ArticleCancers2018

SPARC Inhibits Metabolic Plasticity in Ovarian Cancer.

Christine Naczki, Bincy John, Chirayu Patel, Ashlyn Lafferty, Alia Ghoneum, Hesham Afify, Michael White, Amanda Davis, Guangxu Jin, Steven Kridel and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Metabolic risk factors of ovarian cancer: a review.JBRA assisted reproduction · 2022
    Review
  10. Article
  11. Metabolic reprogramming in epithelial ovarian cancer.American journal of translational research · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Christine NaczkiDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. cmcmahan@wakehealth.edu.
Bincy JohnDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. bincyanujohn@gmail.com.
Chirayu PatelDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. cpatel@wakehealth.edu.ORCID 0000-0003-0649-0090
Ashlyn LaffertyDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. Laffak14@wfu.edu.
Alia GhoneumDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. aghoneum@wakehealth.edu.
Hesham AfifyDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. hafify@wakehealth.edu.
Michael WhiteDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. michawhi@wakehealth.edu.ORCID 0000-0001-6410-6013
Amanda DavisDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. amadavis@wakehealth.edu.
Guangxu JinDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. gjin@wakehealth.edu.
Steven KridelDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. skridel@wakehealth.edu.
Neveen SaidDepartments of Cancer Biology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA. nsaid@wakehealth.edu.
Wake Forest University · USAtrium Health Wake Forest Baptist · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Regulation of Urinary Bladder Carcinogenesis and Progression by SPARCR01CA193437 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI SAID, NEVEEN · 2016 to 2020
$1.8M
NCI NIH HHS P30 CA012197NCI NIH HHS P30CA012197NCI NIH HHS R01 CA193437Rivkin Center for Ovarian Cancer Rivkin Center for Ovarian CancerWake Forest University Department of Pathology Endowment Funds N/A
6 · The paper itself

Abstract

The tropism of ovarian cancer (OvCa) to the peritoneal cavity is implicated in widespread dissemination, suboptimal surgery, and poor prognosis. This tropism is influenced by stromal factors that are not only critical for the oncogenic and metastatic cascades, but also in the modulation of cancer cell metabolic plasticity to fulfill their high energy demands. In this respect, we investigated the role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in metabolic plasticity of OvCa. We used a syngeneic model of OvCa in

Indexed as

glycolysismetabolic plasticityovarian cancerOXPHOSperitoneal metastasisredox homeostasisSPARCsyngeneic model

Identifiers

PMID30332737
PMCPMC6209984
OpenAlexW2897112077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.